USD 0.27
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 525.38 Thousand USD | 634.74% |
2022 | 71.5 Thousand USD | 141.19% |
2021 | 29.64 Thousand USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 10 Thousand USD | 0.0% |
2011 | 16.89 Million USD | 6104.39% |
2010 | 272.25 Thousand USD | -11.2% |
2009 | 306.58 Thousand USD | 85.61% |
2008 | 165.18 Thousand USD | -82.11% |
2007 | 923.44 Thousand USD | 61462.67% |
2006 | 1500.00 USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 33.79 Thousand USD | 13.85% |
2024 Q1 | 29.68 Thousand USD | -94.35% |
2023 Q1 | 22.48 Thousand USD | -68.55% |
2023 Q2 | 22.48 Thousand USD | 0.0% |
2023 Q4 | 525.38 Thousand USD | 2136.74% |
2023 FY | 525.38 Thousand USD | 634.74% |
2023 Q3 | 23.48 Thousand USD | 4.45% |
2022 Q1 | 21.53 Thousand USD | -27.36% |
2022 Q2 | 20.43 Thousand USD | -5.1% |
2022 Q4 | 71.5 Thousand USD | -12.84% |
2022 Q3 | 82.04 Thousand USD | 301.42% |
2022 FY | 71.5 Thousand USD | 141.19% |
2021 Q3 | 123.44 Thousand USD | 112.19% |
2021 Q2 | 58.17 Thousand USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 FY | 29.64 Thousand USD | 0.0% |
2021 Q4 | 29.64 Thousand USD | -75.98% |
2020 Q1 | - USD | 0.0% |
2020 FY | - USD | -100.0% |
2020 Q4 | - USD | 0.0% |
2019 FY | 10 Thousand USD | 0.0% |
2012 Q2 | 20.12 Million USD | -6.29% |
2012 Q3 | 27 Million USD | 34.18% |
2012 Q1 | 21.47 Million USD | 27.14% |
2011 FY | 16.89 Million USD | 6104.39% |
2011 Q4 | 16.89 Million USD | 11.71% |
2011 Q3 | 15.12 Million USD | 161.62% |
2011 Q2 | 5.77 Million USD | 3797.6% |
2011 Q1 | 148.28 Thousand USD | 16.67% |
2010 Q1 | 253.56 Thousand USD | 16.35% |
2010 Q2 | 272.25 Thousand USD | 7.37% |
2010 Q3 | 189.23 Thousand USD | -30.49% |
2010 Q4 | 127.09 Thousand USD | -32.83% |
2010 FY | 272.25 Thousand USD | -11.2% |
2009 Q1 | 218.99 Thousand USD | 75.89% |
2009 FY | 306.58 Thousand USD | 85.61% |
2009 Q4 | 217.93 Thousand USD | 49.46% |
2009 Q3 | 145.81 Thousand USD | -52.44% |
2009 Q2 | 306.58 Thousand USD | 40.0% |
2008 Q2 | 165.18 Thousand USD | -25.86% |
2008 Q1 | 222.78 Thousand USD | -83.35% |
2008 FY | 165.18 Thousand USD | -82.11% |
2008 Q4 | 124.5 Thousand USD | 67.99% |
2008 Q3 | 74.11 Thousand USD | -55.13% |
2007 FY | 923.44 Thousand USD | 61462.67% |
2007 Q3 | 1.12 Million USD | 22.08% |
2007 Q2 | 923.44 Thousand USD | 1127.37% |
2007 Q1 | 75.23 Thousand USD | 31645.57% |
2007 Q4 | 1.33 Million USD | 18.68% |
2006 Q4 | 237.00 USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | 1500.00 USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Avitar, Inc. | 11.59 Million USD | 95.468% |
BioElectronics Corporation | 16.62 Million USD | 96.839% |
CVR Medical Corp. | - USD | -Infinity% |
IR-Med Inc. | 634 Thousand USD | 17.131% |
Medical Supply International USA, Inc. | 677.61 Thousand USD | 22.465% |
Polarean Imaging plc | 2.58 Million USD | 79.64% |
AVITA Medical, Inc. | 19.86 Million USD | 97.355% |
Manhattan Scientifics, Inc. | 2.11 Million USD | 75.194% |
Össur hf. | 688.8 Million USD | 99.924% |
Zecotek Photonics Inc. | 5.86 Million USD | 91.047% |
QHSLab, Inc. | 2.05 Million USD | 74.459% |
Wellstar International, Inc. | 55.99 Million USD | 99.062% |
Össur hf. | 688.8 Million USD | 99.924% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 16.08 Million USD | 96.733% |
Escalon Medical Corp. | 2.94 Million USD | 82.18% |
Aurora Spine Corporation | 6.65 Million USD | 92.104% |
BrainsWay Ltd. | 15.31 Million USD | 96.569% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 6.01 Million USD | 91.262% |
Hamilton Thorne Ltd. | 45.84 Million USD | 98.854% |
Vivos Inc. | 245 Thousand USD | -114.44% |
MicroPort Scientific Corporation | 2.48 Billion USD | 99.979% |
Kelyniam Global, Inc. | 1.01 Million USD | 48.132% |
REMSleep Holdings, Inc. | 275.61 Thousand USD | -90.624% |
CYduct Diagnostics, Inc. | 2.44 Million USD | 78.554% |
Nanomix Corporation | 14.81 Million USD | 96.454% |
Theraclion SA | 13.01 Million EUR | 95.964% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 5.12 Million USD | 89.747% |
Positron Corporation | 2.02 Million USD | 74.068% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.62 Million USD | 85.491% |
Lombard Medical, Inc. | 53.79 Million USD | 99.023% |
ALR Technologies Inc. | 24.5 Million USD | 97.856% |
Stratec SE | 271.97 Million USD | 99.807% |
Vycor Medical, Inc. | 4.31 Million USD | 87.832% |
Heart Tronics, Inc. | 1.09 Million USD | 52.01% |
Nu-Med Plus, Inc. | 2.35 Million USD | 77.726% |
Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 90.407% |
SANUWAVE Health, Inc. | 65.59 Million USD | 99.199% |
VMS Rehab Systems, Inc. | 201.36 USD | -260819.249% |
Guided Therapeutics, Inc. | 5.47 Million USD | 90.404% |
Ingen Technologies, Inc. | 5.7 Million USD | 90.798% |
Odyssey Group International, Inc. | 6.61 Million USD | 92.054% |
United American Healthcare Corporation | 119 Thousand USD | -341.502% |
ECGI Holdings, Inc. | 11.94 Million USD | 95.6% |
Capital Group Holdings, Inc. | 1.32 Million USD | 60.318% |
ADM Tronics Unlimited, Inc. | 1.44 Million USD | 63.675% |
Urologix, Inc. | 12.64 Million USD | 95.845% |
Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 90.264% |
Nexeon MedSystems Inc. | 8.48 Million USD | 93.806% |
SS Innovations International, Inc. | 11.18 Million USD | 95.301% |
Smith & Nephew plc | 4.76 Billion USD | 99.989% |
NIOX Group Plc | 9.8 Million USD | 94.64% |
Fuse Medical, Inc. | 15.11 Million USD | 96.523% |
Broncus Holding Corporation | 10.43 Million USD | 94.964% |
Brain Scientific Inc. | 7.42 Million USD | 92.925% |
Pressure BioSciences, Inc. | 33.8 Million USD | 98.446% |
Health Logic Interactive Inc. | 794.08 Thousand USD | 33.837% |